July 3, 2019 — The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
July 03, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar ...
June 28, 2019
June 17, 2019 – Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) ...
June 17, 2019Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
June 14, 2019 — Quantum Genomics announced the enrollment of the first patient in its QUORUM Phase IIb study of its lead ...
June 14, 2019
June 12, 2019 — In a letter sent to healthcare providers, the U.S. Food and Drug Administration (FDA) validates that ...
June 12, 2019
May 22, 2019 — Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal ...
May 22, 2019
News | Cardiac Resynchronization Therapy Devices (CRT) | Dave Fornell, Editor
May 15, 2019 — A pilot trial has shown His pacing in cardiac resynchronization therapy (CRT) has been shown to ...
May 15, 2019
May 14, 2019 — The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and ...
May 14, 2019
May 6, 2019 — The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis ...
May 06, 2019
Feature | Heart Failure | Will Clifton, M.D.
The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms. As ...
April 29, 2019
April 19, 2019 – Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that the recently ...
April 19, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
March 26, 2019 — A toilet seat-based cardiovascular monitoring system created by a team of Rochester Institute of ...
March 26, 2019
March 22, 2019 — Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist ...
March 22, 2019